Literature DB >> 3722329

Ingestion of a mixed meal does not affect the metabolic clearance rate of biosynthetic human C-peptide.

J Licinio-Paixao, K S Polonsky, B D Given, W Pugh, D Ostrega, B F Frank, A H Rubenstein.   

Abstract

The validity of C-peptide as a peripheral marker of insulin secretion during different physiological conditions depends on the demonstration that C-peptide clearance is constant under these circumstances. Recently biosynthetic human C-peptide, identical in structure to pancreatic human C-peptide, became available for use in human subjects. The present study was undertaken to determine if the metabolic clearance of C-peptide was altered by ingestion of a mixed meal. Eight insulin-dependent diabetic patients received constant iv infusions of biosynthetic human C-peptide which raised the plasma C-peptide concentration to a level of 3.8 +/- 0.2 (+/- SEM) pmol/ml. The MCR of C-peptide was 4.5 +/- 0.3 ml/kg X min. After steady state levels of C-peptide had been reached, each patient consumed a 530 calorie mixed meal. The plasma glucose concentration increased from a baseline value of 104.5 +/- 4.8 mg/dl to a 336 +/- 10 mg/dl 150 min later. This change in plasma glucose was not associated with a significant alteration in the plasma C-peptide concentration and the MCR of the infused C-peptide was not affected by meal ingestion (4.5 +/- 0.3 vs. 4.3 +/- 0.3 ml/kg X min). These results therefore support the validity of using C-peptide as a marker for changes in insulin secretion after mixed meals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722329     DOI: 10.1210/jcem-63-2-401

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Automated chemiluminescent assay for C-peptide.

Authors:  R W Hardy; M Cohn; R J Konrad
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.

Authors:  E Bonora; P Moghetti; M Querena; M Zenere; V Cacciatori; F Tosi; D Travia; G Zoppini; M Muggeo
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

3.  Plasma C-peptide response to oral glucose load in hyperthyroidism.

Authors:  E Bonora; V Manicardi; M Zenere; P Moghetti; C Coscelli; M Muggeo
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

4.  Postprandial oscillations of plasma glucose, insulin and C-peptide in man.

Authors:  C Simon; M Follenius; G Brandenberger
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

5.  Renal and splanchnic exchange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Sjöberg; B L Johansson; J Ostman; J Wahren
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

6.  Insulin and C-peptide plasma levels in patients with severe chronic pancreatitis and fasting normoglycemia.

Authors:  E Bonora; C Rizzi; C Lesi; P Berra; C Coscelli; U Butturini
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

7.  C-Peptide versus insulin: relationships with risk biomarkers of cardiovascular disease in metabolic syndrome in young arab females.

Authors:  A Abdullah; H Hasan; V Raigangar; W Bani-Issa
Journal:  Int J Endocrinol       Date:  2012-08-01       Impact factor: 3.257

8.  Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes.

Authors:  T Montalcini; P Gallotti; A Coppola; V Zambianchi; M Fodaro; E Galliera; M G Marazzi; S Romeo; S Giannini; M M Corsi Romanelli; A Pujia; C Gazzaruso
Journal:  Osteoporos Int       Date:  2015-01-24       Impact factor: 4.507

Review 9.  The clinical utility of C-peptide measurement in the care of patients with diabetes.

Authors:  A G Jones; A T Hattersley
Journal:  Diabet Med       Date:  2013-07       Impact factor: 4.359

10.  Lower Insulin-Dose Adjusted A1c (IDAA1c) Is Associated With Less Complications in Individuals With Type 1 Diabetes Treated With Hematopoetic Stem-Cell Transplantation and Conventional Therapy.

Authors:  Jaquellyne Gurgel Penaforte-Saboia; Carlos Eduardo Barra Couri; Virginia Oliveira Fernandes; Ana Paula Dias Rangel Montenegro; Lívia Aline De Araújo Batista; Lenita Zajdenverg; Carlos Antonio Negrato; Kelen Cristina Ribeiro Malmegrim; Daniela Aparecida Moraes; Juliana Bernardes Elias Dias; Maria Carolina Oliveira; Akhtar Hussain; Marilia Brito Gomes; Renan Magalhães Montenegro
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-19       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.